drugset / Trial / NCT01972854

Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus

NCT01972854

Phase 3 Terminated 92 enrolled Glaukos Corporation
RandomizedParallel-groupSingle-blindTreatment

Summary

The objectives of this study are to evaluate the safety and efficacy of corneal collagen cross-linking performed with VibeX (riboflavin ophthalmic solution) and the KXL System as compared to placebo in impeding the progression of, and/or reducing, maximum corneal curvature.

Timeline

Start
2013-11
Primary completion
2016-03
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Riboflavin Other / unclassified 0.12 % Other

Indications